We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sphere Medical | LSE:SPHR | London | Ordinary Share | GB00B551W951 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.40 | 0.35 | 0.45 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSPHR
RNS Number : 3614I
Sphere Medical Holding plc
30 August 2016
30 August 2016
Sphere Medical Holding plc
("Sphere Medical" or the "Company")
Sphere Medical Expands Sales into Belgium
Sphere Medical Holding plc (AIM: SPHR.L), a leading provider of innovative monitoring and diagnostic devices for the critical care setting, announces the first sale of its Proxima system in Belgium with an initial order to the Universitair Ziekenhuis Brussel, a 700 bed teaching hospital conducting scientific research, which has evaluated the Proxima system during the past year.
After the UK and Germany, Belgium is the third country in which Sphere Medical has sold Proxima devices through its direct sales force.
Dr Wolfgang Rencken, Chief Executive Officer of Sphere Medical, said: "Proxima is an innovative product which offers better patient management during a patient's critical period, and faster and more frequent production of blood gas, electrolyte and metabolite results. We are pleased to bring Proxima to patients around Europe and report sales in three countries now. As we look ahead to the launch of Proxima 4, the opportunity to increase potential coverage from around 10% of critical care patients to 40-50% gives us optimism for the future."
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.
- Ends -
For further information, please contact:
Sphere Medical Holding Tel: +44 (0)1223 875 plc 222 Dr Wolfgang Rencken, Chief Executive Officer Richard Wright, Chief Financial Officer Panmure Gordon Tel: +44 (0) 20 7886 2500 Freddy Crossley (Corporate Finance) Duncan Monteith (Corporate Finance) Tom Salvesen (Corporate Broking) Consilium Strategic Tel: +44 (0) 20 3709 Communications 5700 Mary-Jane Elliott spheremedical@consilium-comms.com Chris Gardner Ivar Milligan Hendrik Thys
Notes for Editors
About Sphere Medical (AIM: SPHR.L)
Sphere Medical is an innovative point-of-care medical device company. Its Proxima platform measures blood gases, electrolytes and metabolites at the patient's bedside and aims to improve patient care and reduce health system costs. The device is currently sold directly to the critical care market via Sphere Medical's sales force in the UK, Germany, The Netherlands and Belgium. For further information, please visit www.spheremedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCPLMBTMBATTIF
(END) Dow Jones Newswires
August 30, 2016 02:01 ET (06:01 GMT)
1 Year Sphere Medical Chart |
1 Month Sphere Medical Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions